RESTORE · 101MS205

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

A randomized study of natalizumab treatment interruption. EudraCT: 2009-017490-38.

Sponsor: BIOGEN

Phase: IV

Area: Movement disorders

Open the current study catalogue